Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours

Eur Urol. 2009 Mar;55(3):658. doi: 10.1016/j.eururo.2008.06.015. Epub 2008 Jun 13.

Authors

Núria Malats, Francisco X Real

PMID: 18584942
DOI: 10.1016/j.eururo.2008.06.015

No abstract available

Publication types

Comment
Editorial

MeSH terms

Carcinoma, Transitional Cell / genetics*
Carcinoma, Transitional Cell / mortality
Carcinoma, Transitional Cell / pathology
Humans
Kidney Neoplasms / genetics*
Kidney Neoplasms / mortality
Kidney Neoplasms / pathology
Mutation*
Neoplasm Invasiveness
Prognosis
Receptor, Fibroblast Growth Factor, Type 3 / genetics*
Survival Rate
Ureteral Neoplasms / genetics*
Ureteral Neoplasms / mortality
Ureteral Neoplasms / pathology
Urinary Bladder Neoplasms / genetics*
Urinary Bladder Neoplasms / mortality
Urinary Bladder Neoplasms / pathology

Substances

FGFR3 protein, human
Receptor, Fibroblast Growth Factor, Type 3